Sandra Ros

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Impact of Psoriasis on Patient Well-Being Across Life Stages: A Cross-Sectional Survey (Inpsight Working Group).

Impact of Psoriasis on Patient Well-Being Across Life Stages: A Cross-Sectional Survey (Inpsight Working Group).

Journal: Psoriasis (Auckland, N.Z.)

Published: March 19, 2026

Well-Being in Psoriasis: Weighting its Components Using Best-worst Scaling Methodology.

Well-Being in Psoriasis: Weighting its Components Using Best-worst Scaling Methodology.

Journal: Dermatology and therapy

Published: June 18, 2025

Designing an integrated care pathway for spondyloarthritis: A Lean Thinking approach.

Designing an integrated care pathway for spondyloarthritis: A Lean Thinking approach.

Journal: Journal of evaluation in clinical practice

Published: May 01, 2024

A Qualitative Tool to Guide in the Interpretation of the Numerical Rating Scale for Pruritus Intensity in Patients with Atopic Dermatitis.

A Qualitative Tool to Guide in the Interpretation of the Numerical Rating Scale for Pruritus Intensity in Patients with Atopic Dermatitis.

Journal: Acta dermato-venereologica

Published: July 17, 2023

Defining well-being in psoriasis: A Delphi consensus among healthcare professionals and patients.

Defining well-being in psoriasis: A Delphi consensus among healthcare professionals and patients.

Journal: Scientific reports

Published: July 13, 2023

The social value of a PASI 90 or PASI 100 response in patients with moderate-to-severe plaque psoriasis in Spain.

The social value of a PASI 90 or PASI 100 response in patients with moderate-to-severe plaque psoriasis in Spain.

Journal: Frontiers in public health

Published: July 22, 2022

Assessing the value contribution of bimekizumab for the treatment of moderate-to-severe psoriasis using a multidisciplinary reflective multi-criteria decision analysis.

Assessing the value contribution of bimekizumab for the treatment of moderate-to-severe psoriasis using a multidisciplinary reflective multi-criteria decision analysis.

Journal: Expert review of pharmacoeconomics & outcomes research

Published: April 11, 2022

Unmet Needs in the Management of Moderate-to-Severe Psoriasis in Spain: A Multidimensional Evaluation.

Unmet Needs in the Management of Moderate-to-Severe Psoriasis in Spain: A Multidimensional Evaluation.

Journal: Acta dermato-venereologica

Published: March 21, 2022

Consensus Statement on the Psychological Needs of Patients With Chronic Inflammatory Skin Diseases.

Consensus Statement on the Psychological Needs of Patients With Chronic Inflammatory Skin Diseases.

Journal: Actas dermo-sifiliograficas

Published: June 04, 2018

Paradoxical Arthritis Due to Ixekizumab in a Patient With Plaque Psoriasis.

Paradoxical Arthritis Due to Ixekizumab in a Patient With Plaque Psoriasis.

Journal: Actas dermo-sifiliograficas

Published: September 17, 2017

The Spanish Psoriasis Patients' Association According to Its Members: Cross-Sectional Descriptive Study of Members' Opinions of the Association's Functions.

The Spanish Psoriasis Patients' Association According to Its Members: Cross-Sectional Descriptive Study of Members' Opinions of the Association's Functions.

Journal: Actas dermo-sifiliograficas

Published: February 19, 2016

Improving patient outcomes in psoriasis: strategies to ensure treatment adherence.

Improving patient outcomes in psoriasis: strategies to ensure treatment adherence.

Journal: Psoriasis (Auckland, N.Z.)

Published: July 17, 2015

Showing 1-12 of 16

Last Updated: 09/26/2026